Use of EndoFLIP and Manometry Prior to G-POEM - Trial NCT04844190
Access comprehensive clinical trial information for NCT04844190 through Pure Global AI's free database. This phase not specified trial is sponsored by Northwestern University and is currently Recruiting. The study focuses on Gastroparesis. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Northwestern University
Timeline & Enrollment
N/A
Apr 15, 2021
Dec 31, 2024
Primary Outcome
Predictive Value of EndoFLIP,Predictive Value of ADM
Summary
The purpose of this study is to assess physiologic response of therapy in patients with
 refractory gastroparesis undergoing Gastric per-oral endoscopic myotomy (G-POEM) using
 endoscopic functional lumen imaging probe (EndoFLIP) and antroduodenal manometry (ADM).
 Refractory gastroparesis will be defined as having delayed gastric emptying at four hours
 (10% retention of stomach contents) on gastric scintigraphy and persistent symptoms despite
 treatment with dietary modification or prokinetic medications. We hypothesize that EndoFLIP
 and high resolution ADM will provide an individualized pyloric functional profile in
 gastroparesis patients that can more accurately predict clinical response to G-POEM.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04844190
Non-Device Trial